Sweden· SE-20080422000042
Cayston 75 mg Pulver till lösning för nebulisator
A medicinal product containing aztreonam, registered in Sweden by Gilead Sciences Ireland UC.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Aztreonam
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20080422000042
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aztreonam in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaCAYSTONGILEAD SCIENCES CANADA INC
- FinlandCaystonGilead Sciences Ireland UC
- FranceCAYSTON 75 mg, poudre et solvant pour solution pour inhalation par nébiliseurGILEAD SCIENCES IRELAND UC (IRLANDE)
- NetherlandsCayston 75 mg, poeder voor verneveloplossingGilead Sciences Ireland UC
- United StatesAZACTAME.R. Squibb & Sons, L.L.C.
- United KingdomAzactam 1g powder for solution for injection vialsKent Pharma (UK) Ltd
- BelgiumAzactam 1 gLaboratoires Delbert
- IrelandAzactam 1 g Powder for Solution for Injection or InfusionAthlone Pharmaceuticals Limited
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Azactam
- Belgium · Azactam
- Spain · Azactam
- Finland · Azactam
- France · Azactam
- United Kingdom (Northern Ireland) · Aztreonam Kent Pharma Uk, Aztreonam Kent Pharma Uk Ltd
- Ireland · Azactam
- Iceland · Cayston
- Liechtenstein · Cayston
- Luxembourg · Azactam
- Norway · Azactam, Cayston
- Portugal · Azactam
- Romania · Azactam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/295301a7-7f4f-46f4-8c67-67b08e4b8c9f GET /v1/drugs/295301a7-7f4f-46f4-8c67-67b08e4b8c9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20080422000042",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20080422000042",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/cayston"
}See everything about aztreonam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.